NCT03833661 2023-10-25
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
EMD Serono
Phase 2 Completed
Clinical Trials
4 trialsNCT04501094 2022-03-22
A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02178358 2022-02-25
A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma
Eli Lilly and Company
Phase 2 Completed
NCT01401062 2019-03-05
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Weill Medical College of Cornell University
Phase 2 Completed